Erectile dysfunction also known as impotence. All men involved in the study had either severe and end stage erectile dysfunction and had no ability to perform sexual intercourse.
Nearly 50 per cent of men who received a 50ml injection of Botox, (botulinum toxin type A, the active component of Botox) as opposed to a placebo recorded significant erectile satisfaction.
Around 25 per cent were able to complete full penetrative sex.
Mr Amr Raheem, a specialist at International Andrology London confirmed the results from the clinical trial.
Mr Raheem said: “Erectile Dysfunction affects half the male population at some point in their lives and causes misery for millions of men.
“It is believed that the smooth muscle relaxation and increased blood flow to a man’s penis from a Botox injection could help him to maintain an erection and may last for up to 6 months.
“This offers a lifeline to both men and their partners and avoids costly surgical procedures.
“We are optimistic about the full trial results and hope to be offering the treatment at International Andrology London in early 2018.”
International Andrology, which is headquartered in London, has supported this international clinical trial in association with experts from Cairo University Medical School.
This follows two small pilot studies undertaken earlier this year by IA and Cairo University with early findings published in the Journal of Sexual Medicine.
The condition can have a range of causes, including narrowing of the blood vessels, a problem usually associated with diabetes, high cholesterol and high blood pressure.
Erectile dysfunction is very common - particularly among older men - and it is estimated that half of all men between the ages of 40 and 70 will have it to some extent.
CREDIT: EXPRESS.CO.UK
0 comments:
Post a Comment